Imtesty,

The most recent MD&A had some new language regarding the timing of the futility analysis (see this post). I asked Clayton about these statements on September 13th and he responded on September 14th with the following:

"The DSMB and the clinical steering committee are in discussions as to the most appropriate timing for the futility analysis, ranging anywhere from 50% to 75% of the events. When a final decision is made it will be announced. The discussions are based solely on statistical analysis factors and not on clinical results."

BearDownAZ